insights_auto
Outlook: 42.9% bullish·0.0% bearish
Go to analysischevron_right
VTRS:NASDAQ
Viatris Inc
$17.61
arrow_downward
-0.17%(-0.030) 1D
Oct 12, 11:31:27 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VTRS...
Open
$17.70
High
$17.79
Low
$17.58
Mkt. cap
20.23B
Avg. vol.
8.85M
Volume
2.28M
Dividend
2.73%
Quarterly dividend
$0.12
Ex-dividend date
Aug 21, 2026
52-wk high
$18.43
52-wk low
$9.73
EPS
-$0.36
Beta
0.86
Shares outstanding
1.15B
No. of employees
30K
Open
$17.70
High
$17.79
Low
$17.58
Mkt. cap
20.23B
Avg. vol.
8.85M
Volume
2.28M
Dividend
2.73%
Quarterly dividend
$0.12
Ex-dividend date
Aug 21, 2026
52-wk high
$18.43
52-wk low
$9.73
EPS
-$0.36
Beta
0.86
Shares outstanding
1.15B
No. of employees
30K
News stories
From web sources and news partners
Seeking Alpha
·
5 hours ago
Viatris: Improved Confidence Drives M&A Action Again (NASDAQ:VTRS)
Yahoo Finance
·
3 days ago
Viatris (VTRS) Buys Pacira As Fair Value Stays In Focus
Reuters
·
4 days ago
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal
Profile
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community.
Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. In 2026, Viatris ranked 100 on Time Magazine's World's Most Impactful Companies. Wikipedia
About Viatris Inc
CEOScott A. Smith
Employees30K
FoundedNov 16, 2020
HeadquartersCanonsburg, Pennsylvania, United States
SectorPharmaceutical industry
Websiteviatris.com